BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schulze A, Oshi M, Endo I, Takabe K. MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer. Int J Mol Sci 2020;21:E8127. [PMID: 33143224 DOI: 10.3390/ijms21218127] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Thakral D, Singh VK, Gupta R, Jha N, Khan A, Kaur G, Rai S, Kumar V, Supriya M, Bakhshi S, Seth R. Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia. Ann Hematol 2023;102:73-87. [PMID: 36527458 DOI: 10.1007/s00277-022-05021-4] [Reference Citation Analysis]
2 Mehdi AM, Zhou C, Turrell G, Walpole E, Porceddu S, Frazer IH, Chandra J. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer. Cancer Gene Ther 2022. [PMID: 36575316 DOI: 10.1038/s41417-022-00577-9] [Reference Citation Analysis]
3 Mosquim Junior S, Siino V, Rydén L, Vallon-Christersson J, Levander F. Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers (Basel) 2022;14. [PMID: 36497242 DOI: 10.3390/cancers14235761] [Reference Citation Analysis]
4 Liu A, Liu Y, Shen S, Yan L, Lv Z, Ding H, Wang A, Yuan Y, Xu Q, Oefner PJ. Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer. BioMed Research International 2022;2022:1-23. [DOI: 10.1155/2022/4009354] [Reference Citation Analysis]
5 An J, Oh JH, Oh B, Oh YJ, Ju JS, Kim W, Kang HJ, Sung CO, Shim JH. Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma. Hepatology 2022. [PMID: 36177702 DOI: 10.1002/hep.32812] [Reference Citation Analysis]
6 Wang Z, Liu D, Yang R, Zheng M. Correlation of Tryptophan Metabolic Pathway with Immune Activation and Chemosensitivity in Patients with Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/2158525] [Reference Citation Analysis]
7 Qin J, Liu X, Wang X, Wang G, Liang Q, Dong Y, Pang K, Hao L, Xue L, Zhao Y, Hu Z, Li R, Lv Q, Chao L, Meng F, Shi Z, Han C. Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker. Front Genet 2022;13:984279. [DOI: 10.3389/fgene.2022.984279] [Reference Citation Analysis]
8 Jiang S, Huang J, He H, Liu Y, Liang L, Sun X, Li Y, Cong L, Qing B, Jiang Y. NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma. Cancers (Basel) 2022;14:4395. [PMID: 36139554 DOI: 10.3390/cancers14184395] [Reference Citation Analysis]
9 Cong F, Long J, Liu J, Deng Z, Yan B, Liang C, Huang X, Liu J, Tang W. An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. Front Genet 2022;13:877468. [DOI: 10.3389/fgene.2022.877468] [Reference Citation Analysis]
10 Kuilman MM, Ellappalayam A, Barcaru A, Haan JC, Bhaskaran R, Wehkamp D, Menicucci AR, Audeh WM, Mittempergher L, Glas AM. BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance. Breast Cancer Res Treat 2022. [PMID: 35984580 DOI: 10.1007/s10549-022-06698-x] [Reference Citation Analysis]
11 Yang F, Zhao Y, Huang X, Zhang J, Zhang T, Sun Y. A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma. Genetics Research 2022;2022:1-11. [DOI: 10.1155/2022/3483498] [Reference Citation Analysis]
12 Kong L, Zhou M, Yang J, Ma T, Feng G, Wang X, Wang L, Ge Y, Gao R, Liu H, Shan L, Chen X. Increased retinoic acid signalling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.. [DOI: 10.21203/rs.3.rs-1798275/v1] [Reference Citation Analysis]
13 Oshi M, Patel A, Wu R, Le L, Tokumaru Y, Yamada A, Yan L, Matsuyama R, Ishikawa T, Endo I, Takabe K. Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer. NPJ Breast Cancer 2022;8:92. [PMID: 35945417 DOI: 10.1038/s41523-022-00466-2] [Reference Citation Analysis]
14 Wu R, Gandhi S, Tokumaru Y, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K. Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer. Breast Cancer Res Treat. [DOI: 10.1007/s10549-022-06661-w] [Reference Citation Analysis]
15 Liu J, Jia J, Wang S, Zhang J, Xian S, Zheng Z, Deng L, Feng Y, Zhang Y, Zhang J. Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer. Molecules 2022;27:4108. [DOI: 10.3390/molecules27134108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ji D, Zhong R, Fan S, Parameshachari BD. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature. BioMed Research International 2022;2022:1-21. [DOI: 10.1155/2022/8740408] [Reference Citation Analysis]
17 Li X, Hou L, Zhang L, Zhang L, Wang D, Wang Z, Wen M, Yang X. OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types. Front Cell Dev Biol 2022;10:815480. [DOI: 10.3389/fcell.2022.815480] [Reference Citation Analysis]
18 Yang X, Tao L, Xu Y, Li S, Yang W, Wang L, Zhu J. CircMYC promotes proliferation, migration, invasion and inhibits apoptosis of small cell lung cancer by targeting miR-145/ Matrix Metallopeptidase 2 axis. Bioengineered 2022;13:10552-63. [PMID: 35441564 DOI: 10.1080/21655979.2022.2062978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tian L, Long F, Hao Y, Li B, Li Y, Tang Y, Li J, Zhao Q, Chen J, Liu M. A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning. Front Med 2022;9:880326. [DOI: 10.3389/fmed.2022.880326] [Reference Citation Analysis]
20 Kwok AWC, Qiao C, Huang R, Sham MH, Ho JWK, Huang Y. MQuad enables clonal substructure discovery using single cell mitochondrial variants. Nat Commun 2022;13:1205. [PMID: 35260582 DOI: 10.1038/s41467-022-28845-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Dziadowicz SA, Wang L, Akhter H, Aesoph D, Sharma T, Adjeroh DA, Hazlehurst LA, Hu G. Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma. Cancers 2022;14:927. [DOI: 10.3390/cancers14040927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li Z, Hu M, Qiu J, Feng J, Zhang R, Wu H, Hu G, Ren J. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation. Med Sci Monit 2022;28:e933447. [PMID: 35027526 DOI: 10.12659/MSM.933447] [Reference Citation Analysis]
23 Falzarano MS, Grilli A, Zia S, Fang M, Rossi R, Gualandi F, Rimessi P, El Dani R, Fabris M, Lu Z, Li W, Mongini T, Ricci F, Pegoraro E, Bello L, Barp A, Sansone VA, Hegde M, Roda B, Reschiglian P, Bicciato S, Selvatici R, Ferlini A. RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing. HGG Adv 2022;3:100054. [PMID: 35047845 DOI: 10.1016/j.xhgg.2021.100054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhong Y, Zhuang Z, Mo P, Lin M, Gong J, Huang J, Mo H, Lu Y, Huang M. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer. PeerJ 2021;9:e12506. [PMID: 34993016 DOI: 10.7717/peerj.12506] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Xu F, Tang Q, Wang Y, Wang G, Qian K, Ju L, Xiao Y. Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer. Front Genet 2021;12:758612. [PMID: 34938313 DOI: 10.3389/fgene.2021.758612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Zhong Y, Zhuang Z, Mo P, Shang Q, Lin M, Gong J, Huang J, Mo H, Huang M. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer. Evid Based Complement Alternat Med 2021;2021:5557873. [PMID: 34567213 DOI: 10.1155/2021/5557873] [Reference Citation Analysis]
27 Yu X, Cao F, Yu Y, Li Y, Zhang J, Xu T, Di Q, Wu G, Zhang Z, Wang R, Li Y. HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric Cancer. DNA Cell Biol 2021;40:1251-60. [PMID: 34491823 DOI: 10.1089/dna.2021.0165] [Reference Citation Analysis]
28 Patel A, Oshi M, Yan L, Matsuyama R, Endo I, Takabe K. The Unfolded Protein Response Is Associated with Cancer Proliferation and Worse Survival in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4443. [PMID: 34503253 DOI: 10.3390/cancers13174443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Tokumaru Y, Oshi M, Huyser MR, Yan L, Fukada M, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer. Sci Rep 2021;11:14134. [PMID: 34239017 DOI: 10.1038/s41598-021-93681-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Yan X, Chen M, Xiao C, Fu J, Sun X, Hu Z, Zhou H. Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer. Ann Med 2021;53:1048-58. [PMID: 34187252 DOI: 10.1080/07853890.2021.1918346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Oshi M, Tokumaru Y, Angarita FA, Lee L, Yan L, Matsuyama R, Endo I, Takabe K. Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. Sci Rep 2021;11:12541. [PMID: 34131208 DOI: 10.1038/s41598-021-91897-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
32 Oshi M, Angarita FA, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K. A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:2401. [PMID: 34065619 DOI: 10.3390/cancers13102401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Kwok AWC, Qiao C, Huang R, Sham M, Ho JWK, Huang Y. MQuad enables clonal substructure discovery using single cell mitochondrial variants.. [DOI: 10.1101/2021.03.27.437331] [Reference Citation Analysis]
34 Oshi M, Tokumaru Y, Mukhopadhyay S, Yan L, Matsuyama R, Endo I, Takabe K. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer. Cells 2021;10:653. [PMID: 33804148 DOI: 10.3390/cells10030653] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
35 Oshi M, Tokumaru Y, Angarita FA, Yan L, Matsuyama R, Endo I, Takabe K. Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer. Cancers (Basel) 2020;12:E3557. [PMID: 33260779 DOI: 10.3390/cancers12123557] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]